Difference between revisions of "Boehringer-Ingelheim"

From Powerbase
Jump to: navigation, search
 
 
(8 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 +
'''Boehringer-Ingelheim''' was founded in Ingelheim, Germany, in 1885. The company under [[Albert Boehringer]] established a reputation for social enlightenment and tehnologically innovative products.<ref>: http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1.htm (Boehringer-Ingelheim history)</ref>
 +
Boehringer introduced benefits to his workforce deemed 'remarkably enlightened and generous for the time', including a health insurance scheme in 1902, annual holiday entitlement employee travel subsidiaries in 1910, and a company pension in 1912.<ref>http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1_3.htm (Boehringer-Ingelheim, Social Welfare Pioneer),</ref>
  
 +
Boehringer-Ingelheim Pharmaceuticals focuses largely on human pharmaceuticals (prescription medicines, consumer health care and biopharmaceuticals. Specific areas of interest are: acute coronary disease, arthritis, COPD, HIV/AIDS, Hypertension, Parkinson’s Disease, Restless Legs Syndrome, Stoke and Thromboembolic Diseases. Wellknown products include Antistax, Buscopan and Dulcolax.<ref>http://www.boehringer-ingelheim.com/corporate/products/index.asp (Boehringer-Ingelheim products)</ref>
 +
 +
Boehringher Ingelheim took $10.84bn in global sales and spent $1,14bn on research and design in 2005.<ref>Gray, N. (2006) Changing Landscapes: A special Report on the World’s Top 50 Pharma Companies, Pharmaceutical Executive. Available online at: pharmexec.findpharma.com/pharmexec/2005-Pharm-Exec-50-revised/ArticleStandard/Article/detail/354138 </ref>
  
 
==Lobbying and PR firms==
 
==Lobbying and PR firms==
 
*[[Chambre Public Affairs]]
 
*[[Chambre Public Affairs]]
 +
*[[Pagefield]]<ref> [http://www.appc.org.uk/members/register/register-profile/?company=Pagefield Register 1st September 2014 - 30th November 2014] ''APPC'', accessed 28 January 2015 </ref>
  
==Notes
+
==Notes==
  
 
<references/>
 
<references/>

Latest revision as of 15:31, 28 January 2015

Boehringer-Ingelheim was founded in Ingelheim, Germany, in 1885. The company under Albert Boehringer established a reputation for social enlightenment and tehnologically innovative products.[1] Boehringer introduced benefits to his workforce deemed 'remarkably enlightened and generous for the time', including a health insurance scheme in 1902, annual holiday entitlement employee travel subsidiaries in 1910, and a company pension in 1912.[2]

Boehringer-Ingelheim Pharmaceuticals focuses largely on human pharmaceuticals (prescription medicines, consumer health care and biopharmaceuticals. Specific areas of interest are: acute coronary disease, arthritis, COPD, HIV/AIDS, Hypertension, Parkinson’s Disease, Restless Legs Syndrome, Stoke and Thromboembolic Diseases. Wellknown products include Antistax, Buscopan and Dulcolax.[3]

Boehringher Ingelheim took $10.84bn in global sales and spent $1,14bn on research and design in 2005.[4]

Lobbying and PR firms

Notes

  1. : http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1.htm (Boehringer-Ingelheim history)
  2. http://www.boehringer-ingelheim.com/corporate/corp/corp_hist1_1_3.htm (Boehringer-Ingelheim, Social Welfare Pioneer),
  3. http://www.boehringer-ingelheim.com/corporate/products/index.asp (Boehringer-Ingelheim products)
  4. Gray, N. (2006) Changing Landscapes: A special Report on the World’s Top 50 Pharma Companies, Pharmaceutical Executive. Available online at: pharmexec.findpharma.com/pharmexec/2005-Pharm-Exec-50-revised/ArticleStandard/Article/detail/354138
  5. Register 1st September 2014 - 30th November 2014 APPC, accessed 28 January 2015